R. Nakahara

Development of a Sensitive and High-Throughput Assay for Simultaneous Quantification of 5 Tyrosine Kinase Inhibitors and 2 Active Metabolites in Human Plasma Using Ultra-high Performance Liquid Chromatography Coupled to Tandem Mass Spectrometry

H. Itoh, Yosuke Suzuki, Ryota Tanaka, 2021, Therapeutic drug monitoring.

Quality of life after prolonged ICU stay: preliminary results of a prospective survey in critically ill patients

A. Zollinger, R. Nakahara, L. Weibel, 2008, Critical Care.

Intervention by Pharmacist in Outpatient Service for Lenvatinib Therapy for Hepatocellular Carcinoma at Our Hospital and Its Usefulness

Ryota Tanaka, R. Tatsuta, Hiroyuki Ono, 2020, Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences).

Successful determination of imatinib re‐administration dosage by therapeutic drug monitoring in a case of chronic myeloid leukemia initiating dialysis for acute renal dysfunction

H. Itoh, Ryota Tanaka, M. Ogata, 2021, Clinical case reports.

Successful determination of nilotinib dosage by therapeutic drug monitoring in a patient with chronic myeloid leukemia developing hepatic dysfunction: A case report

Yuhki Sato, H. Itoh, M. Ogata, 2019, Clinical case reports.

High‐performance Liquid Chromatographic Ultraviolet Detection of Nilotinib in Human Plasma from Patients with Chronic Myelogenous Leukemia, and Comparison with Liquid Chromatography‒Tandem Mass Spectrometry

H. Itoh, R. Nakahara, Yuhki Satho, 2016, Journal of clinical laboratory analysis.

A quantitative method for the determination of bosutinib in human plasma using high‐performance liquid chromatography and ultraviolet detection

H. Itoh, T. Sumimoto, R. Nakahara, 2018, Journal of clinical laboratory analysis.